China Universal Asset Management Company’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $688K | Buy |
24,210
+97
| +0.4% | +$2.76K | 0.06% | 217 |
|
|
2025
Q1 | $712K | Sell |
24,113
-1,185
| -5% | -$35K | 0.07% | 212 |
|
|
2024
Q4 | $736K | Buy |
25,298
+2,772
| +12% | +$80.6K | 0.07% | 202 |
|
|
2024
Q3 | $1.03M | Buy |
22,526
+11,291
| +100% | +$519K | 0.11% | 135 |
|
|
2024
Q2 | $459K | Sell |
11,235
-4,064
| -27% | -$166K | 0.06% | 153 |
|
|
2024
Q1 | $390K | Buy |
15,299
+6,729
| +79% | +$172K | 0.05% | 206 |
|
|
2023
Q4 | $77.6K | Buy |
8,570
+6,675
| +352% | +$60.4K | 0.02% | 316 |
|
|
2023
Q3 | $12.1K | Buy |
1,895
+967
| +104% | +$6.17K | ﹤0.01% | 337 |
|
|
2023
Q2 | $10.3K | Sell |
928
-31
| -3% | -$344 | ﹤0.01% | 315 |
|
|
2023
Q1 | $14.7K | Buy |
959
+406
| +73% | +$6.23K | 0.01% | 250 |
|
|
2022
Q4 | $12.3K | Buy |
553
+65
| +13% | +$1.44K | ﹤0.01% | 208 |
|
|
2022
Q3 | $8K | Buy |
+488
| New | +$8K | ﹤0.01% | 229 |
|